14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026
GRDN vs AAM: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 20, 2026, Guardian Pharmacy Services, Inc. (GRDN) is the stronger overall head-to-head candidate over AA Mission Acquisition Corp. (AAM) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). GRDN carries a Unified Composite Score of 35.9/100 (SELL) at $46.94 (31.3x Forward P/E, 6.5% operating margin), whereas AAM carries 59.9/100 (HOLD) at $10.66 (N/M Forward P/E, 0.0% operating margin).
Composite vs. Pillar Nuance: While AAM currently prints a higher short-term Unified Composite Score (59.9/100 HOLD vs. GRDN 35.9/100 SELL), GRDN captures the overall institutional head-to-head verdict (6–4 matrix metrics and 6–0 across the 6 pillars) due to superior fundamental profitability (6.5% vs. 0.0% operating margin) and revenue trajectory (-1.7% vs. +0.0% YoY).
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on GRDN vs AAM. Trailing 12-month operating profitability (GRDN 6.5% vs AAM 0.0%) and valuation multiples (GRDN 31.3x vs AAM N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Medical Care Facilities value chain with $3.0B market capitalization and 6.5% operating margin.
OpEx & R&D Reinvestment15.9% of Rev ($232M)
90D Engineering Disclosures0 Published
AAM Moat ProfileHigh-Margin Pricing Power Moat
Shell Companies Operator
Competes within the Shell Companies value chain with $467.9M market capitalization and 0.0% operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
Investor FAQ GRDN vs AAM Key Questions & Quantitative Answers
As of Nov 20, 2026, Guardian Pharmacy Services, Inc. (GRDN) is the stronger overall head-to-head candidate over AA Mission Acquisition Corp. (AAM) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). GRDN carries a Unified Composite Score of 35.9/100 (SELL) at $46.94 (31.3x Forward P/E, 6.5% operating margin), whereas AAM carries 59.9/100 (HOLD) at $10.66 (N/M Forward P/E, 0.0% operating margin). Composite vs. Pillar Nuance: While AAM currently prints a higher short-term Unified Composite Score (59.9/100 HOLD vs. GRDN 35.9/100 SELL), GRDN captures the overall institutional head-to-head verdict (6–4 matrix metrics and 6–0 across the 6 pillars) due to superior fundamental profitability (6.5% vs. 0.0% operating margin) and revenue trajectory (-1.7% vs. +0.0% YoY).
GRDN leads the Growth & Scale pillar: GRDN posts -1.7% YoY revenue growth and +88.8% YoY earnings growth on $1.46B TTM revenue (22.4% gross margin, 6.5% operating margin), compared with AAM at +0.0% YoY revenue growth and +10.4% YoY earnings growth on N/A TTM revenue (N/A gross margin, 0.0% operating margin). On trailing 12-month operating scale, GRDN generates $1.46B in USD-normalized revenue versus N/A for AAM. In operating R&D and SG&A reinvestment, GRDN deploys 15.9% of Rev ($232M) (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for AAM.
GRDN screens cheaper on headline valuation multiples. GRDN trades at 31.3x Forward P/E, 39.9x Trailing P/E, N/M PEG, and 2.0x EV/Revenue (6.6% FCF margin), whereas AAM trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against GRDN (32.0% ROE) versus AAM (411.0% ROE) capital efficiency.
In options market volatility and institutional positioning, GRDN carries 41.1% implied volatility (7th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in a SURGE options structure phase (0.51β · 56% Vol realized risk). By comparison, AAM carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.01β · 3% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.